Literature DB >> 6194518

Antidepressant properties of some phosphodiesterase inhibitors.

E Przegaliński, K Bigajska.   

Abstract

Effects of three phosphodiesterase (PDE) inhibitors (rolipram, IBMX, and Ro 20-1724) were studied in mice in some tests predictive for antidepressant activity. All the drugs antagonized reserpine-induced hypothermia and slightly antagonized reserpine-evoked hypoactivity. Rolipram and IBMX were also effective in behavioral despair test. On the other hand, the examined PDE inhibitors did not affect apomorphine-induced hypothermia and did not potentiate the central action of L-DOPA. These results show that psychopharmacological profile of the PDE inhibitors differs from that of classical imipramine-like antidepressants.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194518

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  7 in total

Review 1.  Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors.

Authors:  H Wachtel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

2.  Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives.

Authors:  D Bobon; M Breulet; M A Gerard-Vandenhove; F Guiot-Goffioul; G Plomteux; M Sastre-y-Hernández; M Schratzer; B Troisfontaines; R von Frenckell; H Wachtel
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

3.  Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram.

Authors:  H Wachtel; P A Löschmann
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Chronic treatment with the potential antidepressant drug rolipram: the effect on the behavioural responses to adrenergic and dopaminergic receptor agonists with some biochemical correlates.

Authors:  E Przegaliński; L Baran; J Siwanowicz; G Nowak; L Antkiewicz-Michaluk; J Vetulani
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  Rolipram forms a potent discriminative stimulus in drug discrimination experiments in rats.

Authors:  R Ortmann; J G Meisburger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain.

Authors:  W Kehr; G Debus; R Neumeister
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

7.  Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.

Authors:  Yoshio Tokuhara; Shigeyuki Wakitani; Yuuki Imai; Chizumi Nomura; Masatoshi Hoshino; Koichi Yano; Susumu Taguchi; Mitsunari Kim; Yoshinori Kadoya; Kunio Takaoka
Journal:  J Bone Miner Metab       Date:  2009-06-25       Impact factor: 2.626

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.